Aesica Pharmaceuticals Revenue and Competitors

Aesica is a leading pharmaceutical contract development and manufacturing organisation (CDMO) for both APIs and finished dose forms. Our full service, end-to-end pharmaceutical development and manufacturing solution comprises capabilities in formulation development for API and finished dose, manufacturing at all scales and packaging services.\r\n\r\nWe have state-of-the-art facilities and approximately 1300 colleagues at five development and manufacturing sites in the UK, Germany and Italy, as well as an international office in Shanghai and our Head Office in north London, UK. Our offering is underpinned by our focus on quality, reliability and service, we are aware that customers want more than a supplier, which is why we work in partnership to provide a flexible, efficient and dependable service.\r\n\r\nAs part of the Consort Medical group, our offering has expanded to include end-to-end capabilities in the design, industrialisation and manufacture of medical delivery devices, further simplifying the supply chain and increasing control for our customers.The Aesica vision is to grow the maturity and strength of our organisation through capabilities, reliability and sustainability to enhance the value for our stakeholders. Drive best in class customer service across everything we do through respect, understanding the customer and quality of execution.\r\n\r\n\r\nFor more information please visit our website: www.aesica-pharma.com\r\nAlternatively please contact us: enquiries@aesica-pharma.com or +44 (0) 191 296 0655.